Recipients with blood group A associated with longer survival rates in cardiac valvular bioprostheses - Sorbonne Université Access content directly
Journal Articles EBioMedicine Year : 2019

Recipients with blood group A associated with longer survival rates in cardiac valvular bioprostheses

Abstract

Background: Pigs/bovines share with humans some of the antigens present on cardiac valves. Two such antigens are: the major xenogenic Ag, "Gal" present in all pig/bovine very close to human B-antigen of ABO-blood-group system; the minor Ag, pig histo-blood-group AH-antigen identical to human AH-antigen and present by some animals. We hypothesize that these antigens may modify the immunogenicity of the bioprosthesis and also its longevity. ABO distribution may vary between patients with low (b6 years) and high (≥15 years) bioprostheses longevity. Methods: Single-centre registry study (Paris, France) including all degenerative porcine bioprostheses (mostly Carpentier-Edwards 2nd/3rd generation heart valves) explanted between 1985 and 1998 and some bovine bioprostheses. For period 1998-2014, all porcine bioprostheses with longevity ≥13 years (follow-up ≥29 years). Important predictive factors for bioprosthesis longevity: number, site of implantation, age were collected. Blood group and other variables were entered into an ordinal logistic regression analysis model predicting valve longevity, categorized as low (b6 years), medium (6-14.9 years), and high (≥15 years). Findings: Longevity and ABO-blood group were obtained for 483 explanted porcine bioprostheses. Mean longevity was 10.2 ± 3.9 years [0-28] and significantly higher for A-patients than others (P = 0.009). Using multivariate analysis, group A was a strong predictive factor of longevity (OR 2.09; P b 0.001). For the 64 explanted bovine bioprosthesis with low/medium longevity, the association, with A-group was even more significant. Interpretation: Patients of A-group but not B have a higher longevity of their bioprostheses. Future graft-host phenotyping and matching may give rise to a new generation of long-lasting bioprosthesis for implantation in humans, especially for the younger population.
Fichier principal
Vignette du fichier
1-s2.0-S2352396419301264-main.pdf (657.83 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Licence : CC BY NC ND - Attribution - NonCommercial - NoDerivatives

Dates and versions

hal-04459692 , version 1 (15-02-2024)

Identifiers

Cite

O Schussler, N Lila, T Perneger, P Mootoosamy, J Grau, et al.. Recipients with blood group A associated with longer survival rates in cardiac valvular bioprostheses. EBioMedicine, 2019, 42, pp.54 - 63. ⟨10.1016/j.ebiom.2019.02.047⟩. ⟨hal-04459692⟩
17 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More